2013;381:629 38. 4. Thalji NM, Suri RM, Daly RC, et al. The prognostic impact of concomitant coronary artery bypass grafting during aortic valve surgery: implications for revascularization in the transcatheter era. J Thorac Cardiovasc Surg. 2015;149:451 60. 5. Faroux L, Guimaraes L, Wintzer-Wehekind J, et al. Coronary artery disease and transcatheter aortic valve replacement: JACC state-of-the-art review. J Am Coll Cardiol. 2019;74:362 72. 6. Goel SS, Ige M, Tuzcu EM, et al. Severe aortic stenosis and coronary artery disease implications for management in the transcatheter aortic valve replacement era: a comprehensive review. J Am Coll Cardiol. 2013;62:1 10. 7. Sankaramangalam K, Banerjee K, Kandregula K, et al. Impact of coro- nary artery disease on 30-day and 1-year mortality in patients undergoing transcatheter aortic valve replacement: a meta-analysis. J Am Heart Assoc. 2017;6:e006092. 8. Millan-Iturbe O, Sawaya FJ, L nborg J, et al. Coronary artery disease, revascularization, and clinical outcomes in transcatheter aortic valve re- placement: real-world results from the East Denmark Heart Registry. Cath- eter Cardiovasc Interv. 2018;92:818 26. 9. Witberg G, Regev E, Chen S, et al. The prognostic effects of coronary disease severity and completeness of revascularization on mortality in pa- tients undergoing transcatheter aortic valve replacement. JACC Cardio- vasc Interv. 2017;10:1428 35. 10. Chieffo A, Giustino G, Spagnolo P, et al. Routine screening of coronary artery disease with computed tomographic coronary angiography in place of invasive coronary angiography in patients undergoing transcatheter aortic valve replacement. Circ Cardiovasc Interv. 2015;8:e002025. 11. Rossi A, De Cecco CN, Kennon SRO, et al. CT angiography to evalu- ate coronary artery disease and revascularization requirement before trans-catheter aortic valve replacement. J Cardiovasc Comput Tomogr. 2017;11:338 46. 12. van den Boogert TPW, Vendrik J, Claessen B, et al. 